Qc Arthritis Pain Relief
NDC Package 63868-203-40
Package Information
Qc Arthritis Pain Relief is directionsadults and children 18 years of age and older:use only as directedclean and dry affected areaplace applicator on skin, press firmly and hold to activate the dispensing of liquidmassage into painful area until thoroughly absorbedrepeat as necessary, but no more than 3 to 4 times dailyIF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATERchildren under 18 years of age: ask a doctor. Marketed by Chain Drug Marketing Association Inc., this product is identified by NDC 63868-203 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 792051 - capsaicin 0.15 % Topical Solution
- RxCUI: 792051 - capsaicin 1.5 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63868 - Chain Drug Marketing Association Inc.
- 63868-203 - Qc Arthritis Pain Relief
- 63868-203-40 - 1 BOTTLE, WITH APPLICATOR in 1 BOX / 40 mL in 1 BOTTLE, WITH APPLICATOR
- 63868-203 - Qc Arthritis Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63868-203-40 identifies a specific commercial package of 1 bottle, with applicator in 1 box / 40 ml in 1 bottle, with applicator of Qc Arthritis Pain Relief, labeled by Chain Drug Marketing Association Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Marketing Association Inc. on November 06, 2018. The current certification is valid through December 31, 2020.
How is this Chain Drug Marketing Association Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868020340. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.